Healthcare & Life Sciences
Azafaros
Netherlandsazafaros.com
Azafaros is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 4 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
4
Investors
About Azafaros
Azafaros is a startup based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Azafaros develops therapeutic agents for the treatment of rare metabolic disorders, specifically lysosomal storage disorders, through oral administration of aza-sugar compounds. Their lead program, nizubaglustat, targets neurological symptoms in conditions like GM1/GM2 gangliosidoses and Niemann-Pick type C disease.
Explore Azafaros's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.